Skip to content
- Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
- Leith A, Ribbands A, Kim J, Last M, Barlow S, Yang L, Ghate SR.
- Future Oncol. 2022 Jan 19. doi: 10.2217/fon-2021-1113. Epub ahead of print.
- Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.
- Horton C, Blanco K, Lo MT, Speare V, LaDuca H, Dolinsky J, Kurian AW.
- JNCI Cancer Spectr. 2022 Jan 18; pkac002. doi: 10.1093/jncics/pkac002. eCollection 2022 Jan.